15 October 2018 - - US-based Generex biotechnology Corp. (OTCQB: GNBT) has named Anthony S. Crisci, Esq., CPA has joined the company as the general manager, chief compliance officer and corporate counsel for all of subsidiary NuGenerex's distribution efforts, including its newly acquired eight pharmacies and laboratory from Veneto Holdings, L.L.C., to lead the company in building an end-to-end solution for pharmacy and health management services, the company said.

Crisci, a member of the New York and New Jersey Bar associations, as well as a licensed CPA, has built a stellar career as a business legal executive across a number of regulated industries.

Recently, he has been General Counsel, COO, CFO, and controller for a publicly traded holding company, specialising in financial services and technology software companies.

Previously, he served as corporate counsel for a major health system with USD 1bn in annual revenues, and general counsel for a National Pharmacy Benefit Management company that includes mail and specialty drug dispensing.

Crisci brings a range of capabilities with his legal, business, financial, and regulatory background, and his expertise will be deployed to execute on the company's strategic objectives, including mergers and acquisitions, joint venture and development agreements, in-licensing and out-licensing agreements, and most importantly, long term supply and distributorship agreements for nation-wide pharmacy, laboratory, and medical management services.

Generex Biotechnology Corp., is a biopharmaceutical company that is actively involved in discovery, research, development, and financing of new compounds, therapies, diagnostics, delivery systems, and medical technologies.